> ## Content Index > Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt > Use this file to discover other available public pages before exploring further. # Reagan-Udall Foundation for the Food and Drug Administration - URL: https://www.whiteroseintelligence.com/reagan-udall-foundation-for-the-food-and-drug-administration/ - Published: 1999-01-02T23:04:00.000Z - Updated: 2025-07-14T04:05:34.000Z - Author: Liam Sturgess - Tags: Profiles, #docs, #organization The **Reagan-Udall Foundation for the Food and Drug Administration**, sometimes referred to as the **FDA Foundation**, is an American non-profit organization based in Washington, D.C. It identifies itself as a public-private partnership. It operates independently of the [Food and Drug Administration](https://www.whiteroseintelligence.com/Food-and-Drug-Administration) (FDA), but was mandated by Congress "to help support and promote FDA's regulatory science priorities.”[\[1\]](#fn1) ## History The Reagan-Udall Foundation was established in 2007 by the United States Congress through the passage of the *Food and Drug Administration Amendments Act of 2007*.[\[1:1\]](#fn1) ### COVID-19 In March 2020, at the request of the FDA, the Reagan-Udall Foundation partnered with Friends of Cancer Research to create the COVID-19 Evidence Accelerator.[\[2\]](#fn2) It had a budget of $1,219,555 across 2020 and 2021. One of the studies produced by the COVID-19 Evidence Accelerator was a meta-analysis evaluating the role of hydroxychloroquine and an antibiotic called azithromycin, both alone and in combination, as treatment for COVID-19\. The investigators examined the use of these treatments in late stage disease, rather than its well-established use as an early treatment protocol.[\[3\]](#fn3)[\[4\]](#fn4)[\[5\]](#fn5) The results were published on March 17, 2021, finding that the drugs had little benefit at any stage of treatment of COVID-19.[\[6\]](#fn6) #### Vaccine Confidence Project In the fall of 2020, the FDA recruited the Reagan-Udall Foundation to run a $209,094 “COVID-19 vaccine confidence project” following the recommendations of the [Johns Hopkins Center for Health Security](https://www.whiteroseintelligence.com/Johns-Hopkins-Center-for-Health-Security) (JHCFS) Working Group on Readying Populations for COVID-19 Vaccine.[\[7\]](#fn7)[\[8\]](#fn8) Specifically, the project involved identifying causes of so-called “vaccine hesitancy” in various target populations and developing “a set of messages that responded to their concerns.” These messages were then “delivered to FDA for use in their messaging.” ## Finances Funding for the Reagan-Udall Foundation is made up of an annual $1.25 million budget provided by the FDA, with the remainder coming from grants, donations, research contracts, fundraising events and investment income. The Reagan-Udall Foundation’s annual budget nearly doubled over the COVID-19 period. In 2019, the Foundation’s reported revenue was just over $2.7 million.[\[9\]](#fn9) This jumped to $4.9 million in 2020,[\[10\]](#fn10) and to $5.5 million in 2021.[\[11\]](#fn11) Thus, as of 2021, 77.3% of the Foundation’s grants came from industry or private philanthropic entities that have strong ties to industry.[\[12\]](#fn12) The foundation has received funding through sponsorships and donations from:[\[9:1\]](#fn9)[\[13\]](#fn13)[\[14\]](#fn14) - 5AM Ventures - 505(b)(2) Platform - AbbVie - Adaptive Biotechnologies - Aetion - Aevi Genomic Medicine - Alexandria Real Estate Equities - [Alnylam Pharmaceuticals](https://www.whiteroseintelligence.com/Alnylam-Pharmaceuticals) - Alston & Bird - American Cancer Society - American Society of Clinical Oncology - [Amgen](https://www.whiteroseintelligence.com/Amgen) - Amicus Therapeutics - [AstraZeneca](https://www.whiteroseintelligence.com/AstraZeneca) - [Bayer](https://www.whiteroseintelligence.com/Bayer) - [Bill & Melinda Gates Foundation](https://www.whiteroseintelligence.com/Bill-&-Melinda-Gates-Foundation) - Biogen - Biotechnology Innovation Organization (BIO) - Booz Allen Hamilton - [Bristol-Myers Squibb](https://www.whiteroseintelligence.com/Bristol-Myers-Squibb) - Brown-Hamburg Charitable Gift Fund - Buchanan Ingersoll & Rooney - Casdin Capital - Celgene - Commonwealth Fund - CSL Behring - Consumer Healthcare Products Association - [Deloitte](https://www.whiteroseintelligence.com/Deloitte) - [Eli Lilly](https://www.whiteroseintelligence.com/Eli-Lilly) - EQRx - Explorations in Global Health (ExGloH) - [Flagship Pioneering](https://www.whiteroseintelligence.com/Flagship-Pioneering) - [Food and Drug Administration](https://www.whiteroseintelligence.com/Food-and-Drug-Administration) (FDA) - Foundation Medicine - Friends of Cancer Research - FTI Consulting - Genentech - Gilead Sciences - [Glover Park Group](https://www.whiteroseintelligence.com/Glover-Park-Group) - GRAIL - Greenleaf Health - H3 Biomedicine - Horizon Therapeutics - Hyman, Phelps & McNamara - Illumina - Incyte - Intra-Cellular Therapies - [Janssen](https://www.whiteroseintelligence.com/Janssen) - Jewish Communal Fund - J.M. Smucker Company - [Johnson & Johnson](https://www.whiteroseintelligence.com/Johnson-&-Johnson) - Kaiser Permanente - Kellogg's - Kraft Heinz - Mark McLellan - Medscape - [Merck](https://www.whiteroseintelligence.com/Merck) - Meyers Primary Care Institute - MycoTechnology - Nestlé - Novartis - One Medical Group - Patient-Centered Outcomes Research Institute - PatientsLikeMe - [Pfizer](https://www.whiteroseintelligence.com/Pfizer) - [Pharmaceutical Research and Manufacturers of America](https://www.whiteroseintelligence.com/Pharmaceutical-Research-and-Manufacturers-of-America) (PhRMA) - Point32Health - Rockefeller Foundation - S2G Ventures - Sanofi - Sporos Bioventures - Susan G. Komen - Takeda Pharmaceuticals - Teva - Thermo Fisher Scientific - Thrive Earlier Detection - Ultragenyx Pharmaceutical - USP - Verily Life Sciences - [Vir Biotechnology](https://www.whiteroseintelligence.com/Vir-Biotechnology) - WebMD - Zydowsky Consultants ## Partners Partners of the foundation include:[\[11:1\]](#fn11)[\[10:1\]](#fn10) - CVS Health - Harvard Pilgrim Health Care Initiative - HealthCore - HealthPartners Institute - Humana Healthcare Research - Kaiser Permanente Washington Health Research Institute - Marshfield Clinic Health System - Marshfield Clinic Research Institute - Meyers Health Care Institute - Sutter Health - Vanderbilt University Medical Center ### Grants - [SPARC: Supporting Patient Access, Real-world data, and critical Collaborations](http://archive.today/2022.09.14-230331/https://reporter.nih.gov/search/PGLudxd0b0uvKYTYQuXnVQ/project-details/10187367) - [COVID-19 vaccine confidence project](https://pubmed.ncbi.nlm.nih.gov/34246577/) - [COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients](https://pubmed.ncbi.nlm.nih.gov/33730088/) ## External links - [Campfire Wiki](https://www.campfire.wiki/doku.php?id=reagan-udall%5Ffoundation%5Ffor%5Fthe%5Ffood%5Fand%5Fdrug%5Fadministration) - [Website](https://www.reaganudall.org/) - [Wikipedia](https://en.wikipedia.org/wiki/Reagan-Udall%5FFoundation) ### Further reading - November 30, 2023: "[Conflicts of Interest: The U.S. Food and Drug Administration](https://www.whiteroseintelligence.com/blog/conflicts-of-interest-the-u-s-food-and-drug-administration/)" by [Liam Sturgess](https://www.whiteroseintelligence.com/Liam-Sturgess), Matthew Evans-Cockle and [Deanna McLeod](https://www.whiteroseintelligence.com/Deanna-McLeod), published by the [Canadian Covid Care Alliance](https://www.whiteroseintelligence.com/Canadian-Covid-Care-Alliance) --- 1. 110th Congress. (2007, September 27). *Food and Drug Administration Amendments Act of 2007.* U.S. Government Printing Office. [↩︎](#fnref1) [↩︎](#fnref1:1) 2. *Home.* COVID-19 Evidence Accelerator. Retrieved September 7, 2023, from [↩︎](#fnref2) 3. @CovidAnalysis. *HCQ for COVID-19: real-time analysis of all 551 studies.* C19hcq: COVID-19 HCQ Treatment Analysis. Retrieved September 7, 2023, from [↩︎](#fnref3) 4. Tyson, B., Fareed, G., & Crawford, M. (2022). *Overcoming the COVID-19 darkness: How two doctors successfully treated 7000 patients.* Brian Tyson, M.D. and George C. Fareed, M.D. [↩︎](#fnref4) 5. Leake, J., & McCullough, P. A. (2022). *The courage to face COVID-19: Preventing hospitalization and death while battling the bio-pharmaceutical complex.* Skyhorse Publishing. [↩︎](#fnref5) 6. Stewart, M., Rodriguez-Watson, C., Albayrak, A., Asubonteng, J., Belli, A., Brown, T., Cho, K., Das, R., Eldridge, E., Gatto, N., Gelman, A., Gerlovin, H., Goldberg, S. L., Hansen, E., Hirsch, J., Ho, Y.-L., Ip, A., Izano, M., Jones, J., & Justice, A. C. (2021). COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients. *PLOS ONE, 16*(3), e0248128\. [↩︎](#fnref6) 7. Bhat, A., Browning-McNee, L. A., Ghauri, K., & Winckler, S. (2021). COVID-19 vaccine confidence project. *Journal of the American Pharmacists Association, 62*(1), P288-295.E2\. [↩︎](#fnref7) 8. Brunson, E. K., & Schoch-Spana, M. (2020). A social and behavioral research agenda to facilitate COVID-19 vaccine uptake in the United States. *Health Security, 18*(4). [https://doi.org/10.1089/hs.2020.0106](https://web.archive.org/web/20200913031630/https://www.liebertpub.com/doi/full/10.1089/hs.2020.0106) [↩︎](#fnref8) 9. *Annual Report 2019* (p. 23). (2019). Reagan-Udall Foundation. [https://web.archive.org/web/20220712071448/https://reaganudall.org/sites/default/files/2022-02/Reagan-Udall\_Annual Report 20219\_final\_corrected.pdf](https://web.archive.org/web/20220712071448/https://reaganudall.org/sites/default/files/2022-02/Reagan-Udall%5FAnnual%20Report%2020219%5Ffinal%5Fcorrected.pdf) [↩︎](#fnref9) [↩︎](#fnref9:1) 10. *Annual Report 2020.* (2020). Reagan-Udall Foundation for the FDA. [↩︎](#fnref10) [↩︎](#fnref10:1) 11. Sigal, E. V., Winckler, S. C., & Califf, R. M. (2021). *2021 Annual Report.* Reagan-Udall Foundation. [↩︎](#fnref11) [↩︎](#fnref11:1) 12. Foley, K. E., & Cancryn, A. (2022, August 4). *Clinton-era FDA commissioner to lead external review of key agency offices.* Politico. [↩︎](#fnref12) 13. *2018 Annual Report.* (2018). Reagan-Udall Foundation. [↩︎](#fnref13) 14. *2017 Annual Report.* (2017). Reagan-Udall Foundation. [↩︎](#fnref14)